{"id":"https://openalex.org/W7224568745","doi":"https://doi.org/10.21873/invivo.14519","title":"Characteristics of Hypocalcemia-related Reports in the JADER Database: A Pharmacovigilance Study","display_name":"Characteristics of Hypocalcemia-related Reports in the JADER Database: A Pharmacovigilance Study","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224568745","doi":"https://doi.org/10.21873/invivo.14519","pmid":"https://pubmed.ncbi.nlm.nih.gov/42957237","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13723996"},"language":"en","primary_location":{"id":"doi:10.21873/invivo.14519","doi":"https://doi.org/10.21873/invivo.14519","is_oa":true,"landing_page_url":"https://doi.org/10.21873/invivo.14519","pdf_url":null,"source":{"id":"https://openalex.org/S115443242","display_name":"In Vivo","issn_l":"0258-851X","issn":["0258-851X","1791-7549"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4322764940","host_organization_name":"Stanford University Highwire Press","host_organization_lineage":["https://openalex.org/P4322764940"],"host_organization_lineage_names":["Stanford University Highwire Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In Vivo","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21873/invivo.14519","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065318524","display_name":"Tatsuki Ikeda","orcid":"https://orcid.org/0009-0001-5205-7258","observed_orcids":["https://orcid.org/0009-0001-5205-7258"]},"institutions":[{"id":"https://openalex.org/I4405284517","display_name":"Iwate Medical University Hospital","ror":"https://ror.org/03q103q78","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284517"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"TATSUKI IKEDA","raw_affiliation_strings":["Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan; tatsuki.ikeda@j.iwate-med.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan; tatsuki.ikeda@j.iwate-med.ac.jp","institution_ids":["https://openalex.org/I4405284517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035470630","display_name":"Satoru Nihei","orcid":"https://orcid.org/0000-0003-3179-677X","observed_orcids":["https://orcid.org/0000-0003-3179-677X"]},"institutions":[{"id":"https://openalex.org/I180680657","display_name":"Iwate Medical University","ror":"https://ror.org/04cybtr86","country_code":"JP","type":"education","lineage":["https://openalex.org/I180680657"]},{"id":"https://openalex.org/I4405284517","display_name":"Iwate Medical University Hospital","ror":"https://ror.org/03q103q78","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284517"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"SATORU NIHEI","raw_affiliation_strings":["Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","institution_ids":["https://openalex.org/I4405284517"]},{"raw_affiliation_string":"Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan","institution_ids":["https://openalex.org/I180680657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031507482","display_name":"Kazuki Saito","orcid":"https://orcid.org/0000-0003-1117-7648","observed_orcids":["https://orcid.org/0000-0003-1117-7648"]},"institutions":[{"id":"https://openalex.org/I180680657","display_name":"Iwate Medical University","ror":"https://ror.org/04cybtr86","country_code":"JP","type":"education","lineage":["https://openalex.org/I180680657"]},{"id":"https://openalex.org/I4405284517","display_name":"Iwate Medical University Hospital","ror":"https://ror.org/03q103q78","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284517"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KAZUKI SAITO","raw_affiliation_strings":["Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","institution_ids":["https://openalex.org/I4405284517"]},{"raw_affiliation_string":"Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan","institution_ids":["https://openalex.org/I180680657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049116448","display_name":"Kenzo Kudo","orcid":"https://orcid.org/0009-0006-9902-3449","observed_orcids":["https://orcid.org/0009-0006-9902-3449"]},"institutions":[{"id":"https://openalex.org/I180680657","display_name":"Iwate Medical University","ror":"https://ror.org/04cybtr86","country_code":"JP","type":"education","lineage":["https://openalex.org/I180680657"]},{"id":"https://openalex.org/I4405284517","display_name":"Iwate Medical University Hospital","ror":"https://ror.org/03q103q78","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284517"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"KENZO KUDO","raw_affiliation_strings":["Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Iwate Medical University Hospital, Yahaba, Japan","institution_ids":["https://openalex.org/I4405284517"]},{"raw_affiliation_string":"Division of Clinical Pharmaceutics and Pharmacy Practice, Department of Clinical Pharmacy, School of Pharmacy, Iwate Medical University, Yahaba, Japan","institution_ids":["https://openalex.org/I180680657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82809085,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"6","first_page":"3830","last_page":"3842"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-induced-hypocalcemia","display_name":"drug-induced hypocalcemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6830000281333923},{"id":"https://openalex.org/keywords/denosumab","display_name":"denosumab","score":0.8330000042915344},{"id":"https://openalex.org/keywords/zoledronic-acid","display_name":"zoledronic acid","score":1.0},{"id":"https://openalex.org/keywords/bone-modifying-agents","display_name":"bone-modifying agents","score":0.878000020980835},{"id":"https://openalex.org/keywords/hypomagnesemia","display_name":"hypomagnesemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/electrolyte-imbalance","display_name":"electrolyte imbalance","score":0.7609999775886536},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.878000020980835},{"id":"https://openalex.org/keywords/acid-related-disorders","display_name":"acid-related diseases","score":0.8389999866485596},{"id":"https://openalex.org/keywords/jader-database","display_name":"JADER database","score":0.6970000267028809},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9351000189781189},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8066999912261963},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.7343999743461609},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6995000243186951},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4758000075817108},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4138000011444092},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.4074999988079071},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.4068000018596649},{"id":"https://openalex.org/C2777436895","wikidata":"https://www.wikidata.org/wiki/Q2045717","display_name":"Summary of Product Characteristics","level":3,"score":0.3833000063896179},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3828999996185303},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.3682999908924103},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.3499999940395355},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3456999957561493},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.34459999203681946},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3222000002861023},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.30709999799728394},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.30239999294281006},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.30230000615119934},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2793000042438507},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.2727000117301941},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2711000144481659},{"id":"https://openalex.org/C2776183862","wikidata":"https://www.wikidata.org/wiki/Q3771629","display_name":"Hypomagnesemia","level":3,"score":0.26930001378059387},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.2624000012874603},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.25279998779296875}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006996","descriptor_name":"Hypocalcemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006996","descriptor_name":"Hypocalcemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D006996","descriptor_name":"Hypocalcemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.21873/invivo.14519","doi":"https://doi.org/10.21873/invivo.14519","is_oa":true,"landing_page_url":"https://doi.org/10.21873/invivo.14519","pdf_url":null,"source":{"id":"https://openalex.org/S115443242","display_name":"In Vivo","issn_l":"0258-851X","issn":["0258-851X","1791-7549"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4322764940","host_organization_name":"Stanford University Highwire Press","host_organization_lineage":["https://openalex.org/P4322764940"],"host_organization_lineage_names":["Stanford University Highwire Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In Vivo","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13723996","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13723996/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13723996/pdf/in_vivo-40-3830.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In Vivo","raw_type":"Text"},{"id":"pmid:42957237","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42957237","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In vivo (Athens, Greece)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.21873/invivo.14519","doi":"https://doi.org/10.21873/invivo.14519","is_oa":true,"landing_page_url":"https://doi.org/10.21873/invivo.14519","pdf_url":null,"source":{"id":"https://openalex.org/S115443242","display_name":"In Vivo","issn_l":"0258-851X","issn":["0258-851X","1791-7549"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4322764940","host_organization_name":"Stanford University Highwire Press","host_organization_lineage":["https://openalex.org/P4322764940"],"host_organization_lineage_names":["Stanford University Highwire Press"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"In Vivo","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224568745.pdf","grobid_xml":"https://content.openalex.org/works/W7224568745.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403763677","https://openalex.org/W2752130896","https://openalex.org/W2788337141","https://openalex.org/W7143607916","https://openalex.org/W4404220301","https://openalex.org/W7155711489","https://openalex.org/W2515092636","https://openalex.org/W2183173950","https://openalex.org/W2957349772","https://openalex.org/W2050947917"],"abstract_inverted_index":{"BACKGROUND/AIM:":[0],"Drug-induced":[1],"hypocalcemia":[2,32,213],"is":[3],"a":[4,17,208],"clinically":[5],"important":[6],"electrolyte":[7,167,197,220],"disorder.":[8],"Several":[9],"medications":[10],"are":[11],"known":[12],"to":[13,29,59],"induce":[14],"hypocalcemia;":[15],"however,":[16],"comprehensive":[18,209,219],"evaluation":[19],"across":[20,189],"therapeutic":[21,191],"classes":[22],"remains":[23],"limited.":[24],"Therefore,":[25],"this":[26],"study":[27,50],"aimed":[28],"characterize":[30],"drug-induced":[31,212],"using":[33,53,66],"data":[34],"from":[35,56],"the":[36,67,119,136,147,159,164,182,216],"Japanese":[37],"Adverse":[38],"Drug":[39],"Event":[40],"Report":[41],"(JADER)":[42],"database.":[43],"PATIENTS":[44],"AND":[45],"METHODS:":[46],"This":[47],"retrospective":[48],"pharmacovigilance":[49],"was":[51],"conducted":[52],"JADER":[54],"reports":[55,63,109,186],"April":[57],"2004":[58],"February":[60],"2026.":[61],"Hypocalcemia-related":[62,185],"were":[64,86,101,110,118,154,177,187,201],"identified":[65,188],"preferred":[68],"terms":[69],"\"hypocalcemia,\"":[70],"\"hypocalcemic":[71],"seizure,\"":[72],"and":[73,81,91,114,125,132,172,214],"\"blood":[74],"calcium":[75],"decreased.\"":[76],"Reporting":[77],"odds":[78],"ratios":[79],"(RORs)":[80],"95%":[82],"confidence":[83],"intervals":[84],"(CIs)":[85],"calculated":[87],"for":[88,140,174],"suspected":[89,123],"drugs":[90,124,173],"second-level":[92],"Anatomical":[93],"Therapeutic":[94],"Chemical":[95],"(ATC)":[96],"classifications.":[97],"Concomitant":[98,151,196],"adverse":[99,152],"events":[100,153],"also":[102,178],"evaluated.":[103],"RESULTS:":[104],"In":[105],"total,":[106],"1,448":[107],"hypocalcemia-related":[108],"identified.":[111],"Denosumab":[112],"(n=595)":[113],"zoledronic":[115],"acid":[116],"(n=213)":[117],"most":[120,165],"frequently":[121,179,202],"reported":[122],"demonstrated":[126],"strong":[127],"reporting":[128],"signals":[129],"(ROR":[130],"185.20":[131],"46.57,":[133],"respectively).":[134],"Among":[135],"ATC":[137],"classifications,":[138],"Drugs":[139],"Treatment":[141],"of":[142,158,211,218],"Bone":[143],"Diseases":[144],"(M05)":[145],"showed":[146],"strongest":[148],"signal":[149],"(ROR=84.23).":[150],"present":[155],"in":[156,181,222],"50.9%":[157],"reports,":[160],"with":[161],"hypomagnesemia":[162],"being":[163],"common":[166],"abnormality":[168],"(14.5%).":[169],"Antineoplastic":[170],"agents":[171],"acid-related":[175],"disorders":[176],"recorded":[180],"reports.":[183],"CONCLUSION:":[184],"multiple":[190],"classes,":[192],"particularly":[193,199],"bone-modifying":[194],"agents.":[195],"abnormalities,":[198],"hypomagnesemia,":[200],"reported.":[203],"Overall,":[204],"these":[205],"findings":[206],"provide":[207],"overview":[210],"support":[215],"importance":[217],"monitoring":[221],"clinical":[223],"practice.":[224]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-10-30T00:00:00"}